Another study showed that PTEN expression, which is lost in many cancers, can be restored through the activity of a CRISPR system in melanoma and breast cancer cell lines, and hence help reduce migration and colony forming abilities in vitro, implying that the use of CRISPR may be beneficial to help battle against highly aggressive cancers (Moses et al., 2019). Here, PTEN is linked to cancer.